EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature

Eirini Kaisari, Hana Abouzeid, Laurent Magnin, Melanie Boeuf, Evangelia Gkaragkani, Ann Schalenbourg, Thomas J Wolfensberger, Pierre-François Kaeser

Klinische Monatsblätter für Augenheilkunde · 01.04.2024 · 241 (04) · 554-558

DOI: 10.1055/a-2244-6160 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2024. Verfasst von Eirini Kaisari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Jules-Gonin Eye Hospital, University of Lausanne, Switzerland. Hauptthemen laut MEDLINE: Acetazolamide, Myopia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the case of a 32-year-old male who presented with an acute myopic shift as a result of uveal effusion following a single administration of 250 mg acetazolamide. The drug was discontinued and following cycloplegia and topical steroid therapy, we observed progressive deepening of the anterior chamber, reopening of the iridocorneal angle, and complete resolution of the myopic shift after 5 days. A literature review since 1956 identified 23 cases, including ours, which developed a myopic shift after a median time of 24 h (3 – 24) following a median dose of 500 mg (125 – 1000) acetazolamide, with about a third complicated by angle closure ocular hypertension. This presumed idiosyncratic reaction can occur without prior drug exposure and independent of the phakic status. Treatment options include systematic drug withdrawal associated with cycloplegia, anti-glaucomatous agents, and/or corticosteroids. Full recovery is achieved within about 5 days (2 – 14). Given the widespread use of acetazolamide, awareness of this idiosyncratic reaction is crucial to avoid complications of acute angle-closure glaucoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetazolamideMyopiaHumansMaleAdultCarbonic Anhydrase InhibitorsAcute DiseaseTreatment Outcome

Substanzen

AcetazolamideCarbonic Anhydrase Inhibitors

Autor:innen und Institutionen

  • Department of Ophthalmology, Jules-Gonin Eye Hospital, University of Lausanne, Switzerland.
  • Ophthalmology, AZ Ophtalmologie, Geneva, Switzerland.

Zitieren

APA

Kaisari, E., Abouzeid, H., Magnin, L., Boeuf, M., Gkaragkani, E., Schalenbourg, A., Wolfensberger, T. J., & Kaeser, P. F. (2024). Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature. Klinische Monatsblätter für Augenheilkunde, 241(04), 554-558. https://doi.org/10.1055/a-2244-6160

Vancouver

Kaisari E, Abouzeid H, Magnin L, Boeuf M, Gkaragkani E, Schalenbourg A, et al. Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature. Klinische Monatsblätter für Augenheilkunde. 2024;241(04):554-558. doi:10.1055/a-2244-6160

BibTeX
@article{Kaisari2024,
  author = {Kaisari, Eirini and Abouzeid, Hana and Magnin, Laurent and Boeuf, Melanie and Gkaragkani, Evangelia and Schalenbourg, Ann and Wolfensberger, Thomas J and Kaeser, Pierre-François},
  title = {Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2024},
  volume = {241},
  number = {04},
  pages = {554--558},
  doi = {10.1055/a-2244-6160}
}
Kostenlos starten →